期刊文献+

介入治疗对非小细胞肺癌患者炎性因子的影响 被引量:11

Effects of interventional treatment on inflammatory cytokines in patients with non-small cell lung cancer
原文传递
导出
摘要 目的探讨介入治疗对非小细胞肺癌(NSCLC)患者炎性因子的影响。方法 76例不可切除的NSCLC患者随机分为介入组和静脉化疗组,静脉化疗组给予常规静脉化疗方案,每月化疗1次,连续化疗3次。介入组给予支气管动脉灌注化疗术联合支气管动脉栓塞术,介入治疗每月治疗1次,连续治疗3次。在治疗前1周及第3次治疗后分别采集两组患者静脉血,检测外周血的肿瘤坏死因子α(tumor necrosis factor-α,TNF-α)、C反应蛋白(c-reation receptor protein,CRP),降钙素原(procalcitonin,PCT),并进行比较。结果介入组治疗后三种炎症因子明显降低,与术前及静脉化疗组相比,差异具有统计学意义(P<0.05)。介入治疗组有效率72.5%,静脉化疗组38.9%(χ2=8.713,P=0.003),TNF-α、CRP、PCT在治疗后介入组分别为(35.89±19.53)ng/L、(10.36±2.14)mg/L、(2.48±1.51)μg/L,静脉化疗分别为(39.54±17.32)ng/L、(10.31±2.54)mg/L、(2.64±0.94)μg/L。结论介入治疗可以有效降低NSCLC患者炎性因子水平。 Objective To investigate the effects of interventional treatment on inflammatory cytokines in patients with non-small cell lung cancer. Methods A total of 76 patients with non-small lung cancer were randomly divided into interventional treatment group and control group. 36 cases in control group were treated with intravenous chemotherapy. 40 cases in interventional treatment group were treated with BAI( bronchial arterial infusion) + BAE( bronchial arterial embolization). Venous sampling was carried out before treatment and after the third treatment. The of serum CRP( c-reation protein),TNF-α( tumor necrosis factor-α),PCT( procalcitonin) of the two groups were compared statistically. Results There were significant differences between the serum concentration changes of the inflammatory factors before and after therapy in every group and in comparison between every two groups(P〈0. 05). effective rate was 72. 5% in interventional treatment group,38. 9% in control group( χ2= 8. 713,P = 8. 713),TNF-α,CRP and PCT were( 35. 89 ± 19. 53)ng / L,( 10. 36 ± 2. 14) mg / L,( 2. 48 ± 1. 51) μg / L in the interventional treatment group respectively,( 39. 54 ± 17. 32) ng/L,( 10. 31 ± 2. 54) mg/L,( 2. 64 ± 0. 94) μg/L in control group respectively. Conclusion The interventional treatment can reduce the level of serum inflammatory factors in Patients with Non-small cell lung cancer.
出处 《中华肺部疾病杂志(电子版)》 CAS 2015年第3期36-39,共4页 Chinese Journal of Lung Diseases(Electronic Edition)
关键词 肺癌 介入治疗 栓塞 静脉化疗 Lung cancer Interventional treatment Embolization Intravenous chemotherapy
  • 相关文献

参考文献21

  • 1任成山,白莉,钱桂生.慢性阻塞性肺疾病合并肺癌临床特征及新理念[J].中华肺部疾病杂志(电子版),2015,8(2):1-5. 被引量:66
  • 2Alama A, Truini A, Coco S, et al. Prognostic and predictive relevance of circulating tumor cells in patients with non-small-cell lung cancer[J]. Drug Discov Today, 2014,19(10): 1671-1676. 被引量:1
  • 3Kisluk J, Cihorowski M, Niemira M, et al. Proteomics biomarkers for non-small cell lung cancer[J]. J Pharm Biomed Anal, 2014, 101: 4049. 被引量:1
  • 4罗祖炎,刘子江,袁建华,俞文强,陈方宏,蔡学祥,胡庭杨,孔颂阳,赵仲生.支气管动脉灌注化疗治疗非小细胞肺癌的组织学疗效(附63例分析)[J].医学影像学杂志,2000,10(3):137-139. 被引量:4
  • 5陈赐慧,花宝金.炎症和炎性微环境在肺癌发生、发展及转移中的作用[J].医学综述,2012,18(23):3953-3956. 被引量:25
  • 6Engels EA. Inflammation in the development of lung cancer: epidemiological evidence[J]. Expert Rev Anticancer Ther, 2008, 8 ( 4 ) : 605 -615. 被引量:1
  • 7Yang YF, Jan YH, Liu YP, et al. Squalene synthase induces tumor necrosis factor receptor 1 enrichment in lipid rafts to promote lung cancer metastasis[J]. Am J Respir Crit Care Med, 2014, 190 ( 6) : 675-687. 被引量:1
  • 8Tan CS, Read JA, l'han VH, et al. The relationship between nutritional status, inflammatory markers and survival in patients with advanced cancer: a prospective cohort study[J]. Support Care Cancer, 2015, 23(2): 385-391. 被引量:1
  • 9Uribarri M, Hormaeche I, Zalacain R, et al. A New Biomarker Panel in Bronchoalveolar Lavage for an Improved Lung Cancer Diagnosis[J]. J Thorac Oncol, 2014, 9(10): 1504-1512. 被引量:1
  • 10Patout M, Salaun M, Brunei V, et al. Diagnostic and prognostic value of serum procalcitonin concentrations in primary lung cancers[J]. Clin Biochem, 2014, 47 (18) : 263-267. 被引量:1

二级参考文献149

共引文献292

同被引文献136

引证文献11

二级引证文献70

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部